- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06650696
Effects of Parent-Adolescent Joint I-Interventions for Adolescents with Adverse Childhood Experiences (EASY-PEP-i)
November 29, 2024 updated by: Yinyin Zang, PhD, Peking University
Effects of Parent-Adolescent Joint Internet Interventions for Adolescents with Adverse Childhood Experiences: a Cluster Randomized Controlled Trial
The study aims to examine the effectiveness of internet-based Parent-Adolescent Joint Interventions in improving the mental health outcomes of participants, specifically by reducing symptoms of depression, anxiety, and PTSD, as measured by the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder-7 scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5).
Adolescents will be recruited from middle schools and randomly assigned to one of three groups: (a) psychoeducation, (b) psychoeducation + emotional skills enhancement, or (c) psychoeducation + emotional skills enhancement + positive childhood experience promotion.
The school-based intervention will consist of 4-8 sessions, with assessments conducted at baseline, post-treatment, and a 3-month follow-up.
Investigators will conduct multilevel models (MLMs) and structural equation models (SEMs) to investigate the impact of Adverse Childhood Experiences (ACEs), Positive Childhood Experiences (PCEs), alexithymia, and emotion regulation abilities on mental health outcomes in adolescents.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Baoding, Hebei, China
- Diannan middle school
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Middle school students studying in school and their parents
- Capable of hearing, speaking, reading, and writing
Exclusion Criteria:
- High suicidal risks
- Severe mental disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Psychoeducation group (PsyE)
Psychoeducation consists of parent and adolescent psychoeducation.
The content includes an introduction to stress, emotional distress and mental disorders.
|
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
|
|
Experimental: Psychoeducation + Emotional Skills (PsyE+EmoS)
Psychoeducation includes sessions for both parents and adolescents, offering the same content as the control group, which introduces stress, emotional distress, and mental disorders via online programe.
In addition, the emotional skills enhancement sessions provide online materials focused on emotional awareness and emotion regulation strategies, along with tasks related to the content.
Participants will also be required to complete a weekly writing assignment, upload their written contents, and assess their level of subjective discomfort following each writing exercise.
|
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
This intervention combines online material with practical, emotion-focused activities.
Participants will receive training online on emotional awareness and emotion regulation strategies, along with completing weekly writing assignments.
These assignments focus on recent negative events and the emotions associated with them, encouraging emotional expression and processing.
|
|
Experimental: Psychoeducation + emotional skills + PCE (PsyE+EmoS+PoCE)
In comparison to the PsyE+EmoS group, this group additionally requires parents to complete a weekly parent-child communication task via online programe aimed at fostering positive childhood experiences.
Parents are also expected to document and upload the details of these tasks each week.
|
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
This intervention combines online material with practical, emotion-focused activities.
Participants will receive training online on emotional awareness and emotion regulation strategies, along with completing weekly writing assignments.
These assignments focus on recent negative events and the emotions associated with them, encouraging emotional expression and processing.
The intervention requires parents to complete a weekly parent-child interaction task online designed to foster positive childhood experiences.
Parents will engage in structured activities with their children and document the interactions.
Each week, they are expected to upload a report.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Irritability
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85).
A higher score represents higher irritability.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
PTSD for adolescents
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80).
A higher score represents worse PTSD symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Resilience
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item resilience measurement scale, the Connor-Davidson resilience scale, measures resilience on a 5-point Likert scale (score from 0 to 4, and total score varies from 0 to 40).
A higher score represents better resilience .
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Emotion awareness
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, and total scores vary from 30 to 90).
A higher score represents better emotion awareness.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Emotion regulation
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90).
A higher score represents better emotion regulation.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Depression
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The 9-item patient health questionnaire (PHQ-9) for adults (score from 0 to 3, and total score varies from 0 to 27).
A higher score represents worse depression symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Generalized anxiety disorder
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21).
A higher score represents worse anxiety symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Alexithymia
Time Frame: baseline, post treatment(1 month), 3 month follow-up
|
A 36-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 36 to 180).
A higher score represents more severe alexithymia.
|
baseline, post treatment(1 month), 3 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-esteem
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item self-esteemmeasurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Subjective Happiness Scale
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28).
A higher score represents a happier state.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Seeking for help
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item help-seeking scale measures on a 7-point Likert scale (score from 1 to 7, and total score varies from 10 to 70), with higher scores indicating greater willingness to seek help from others.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Insomnia Severity
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI).
This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32).
Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.
|
baseline, post treatment(1 month), 3 month after post treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Game Addiction Scale
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 7-item game addiction scale, measures game addiction on a 5-point Likert scale (score from 1 to 5, and total score varies from 7 to 35), with higher scores indicating worse game addiction.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Suicide
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The suicidal behaviors questionnaire-revised (SBQ-R) for adolescents and children (total scores vary from 3 to 18).
A higher score represents a higher suicide risk.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Social support
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The 12-item Multidimensional Scale of Perceived Social Support (score from 1 to 7, and total score varies from 12 to 84).
A higher score represents better social support.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Positive Childhood Experiences
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A questionnaire measuring positive childhood experiences with 13 items(total scores vary from 0 to 64).
A higher score represents a more positive childhood experiences.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Behavior performances
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 22-item behavior performance questionnaire measures various behavior performances such as study time, phone use, school performance, drinking alcohol, smoking, stealing, fighting, and lying.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Adverse events
Time Frame: baseline, post treatment(1 month)
|
A 6-item questionnaire asks about adverse events since last month, including self-harm, experiencing emotional abuse, experiencing physical abuse, feeling severe distress, mental illness events (e.g., panic attack), and physical injury.
|
baseline, post treatment(1 month)
|
|
Non-suicidal self-injury
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The non-suicidal self-injury assessment tool (NSSI-AT-Severity) for adolescents and children (total scores vary from 5 to 16).
A higher score represents a worse self-injury situation.
|
baseline, post treatment(1 month), 3 month after post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 27, 2024
Primary Completion (Estimated)
June 30, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
October 18, 2024
First Submitted That Met QC Criteria
October 18, 2024
First Posted (Actual)
October 21, 2024
Study Record Updates
Last Update Posted (Estimated)
December 2, 2024
Last Update Submitted That Met QC Criteria
November 29, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Joint i-Tx for Adolscents ACEs
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Emotional
-
Lawson Health Research InstituteWestern UniversityCompleted
-
Prof. dr. Filip RaesCompleted
-
Stanford UniversityCompletedStress, EmotionalUnited States
-
Hospital Israelita Albert EinsteinCompletedEmotional StressBrazil
-
University of SussexCompleted
-
Boston Medical CenterCompletedStress, EmotionalUnited States
-
Lawson Health Research InstituteRecruiting
-
Babes-Bolyai UniversityCompletedEmotional StressRomania
-
University of California, San FranciscoCompleted
-
Hospital Israelita Albert EinsteinCompleted
Clinical Trials on Psychoeducation
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
The University of Texas Health Science Center,...TerminatedBipolar Disorder Family MembersUnited States
-
The Hong Kong Polytechnic UniversityHealth and Medical Research FundNot yet recruitingCaregiving Stress
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAlzheimer's Association; University of BergamoCompleted
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
University of Alabama at BirminghamCompletedChronic Low Back PainUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Virginia; Autism Speaks; National Center for Advancing Translational...CompletedAutism Spectrum DisorderUnited States
-
Istanbul Medeniyet UniversityCompletedElderly People | Depressive Symptoms | DespondencyTurkey
-
Kilis 7 Aralik UniversityActive, not recruiting
-
University of Missouri, Kansas CityUniversity of KansasCompletedMultiple SclerosisUnited States